This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

oral contraceptive pill and cardiovascular risk

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

Arterial thromboembolic disease

Current use of CHC (combined hormonal contraception) is associated with a very small increased risk of myocardial infarction (MI) and ischaemic stroke that appears to be greater with higher doses of estrogen in COC.

Women should be informed that current use of CHC is associated with an increased risk of MI and ischaemic stroke but that that these events are still extremely uncommon in CHC users.

Use of CHC by women with significant additional risk factors for arterial disease should be strongly cautioned or avoided

Reference:

  • FSRH (July 2019). Combined Hormonal Contraception

Links:

The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.